全球組織診斷市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

組織診斷市場預計將從 2025 年的 72.4 億美元成長到 2034 年的 157.8 億美元，2026 年至 2034 年的複合年成長率為 9.04%。

受癌症患者數量不斷增加以及對精準快速診斷解決方案需求日益成長的推動，組織診斷市場預計將迎來顯著成長。隨著醫療機構致力於透過早期檢測和個人化治療方案改善患者預後，對先進組織診斷技術的需求呈現爆炸性成長。組織病理學、免疫組織化學和分子診斷領域的創新正在提高組織分析的準確性和效率，使醫療專業人員能夠就患者照護做出明智的決策。數位病理學和人工智慧的整合正在進一步變革該領域，實現更精確的影像分析和更最佳化的檢查室工作流程。

此外，對個人化醫療日益成長的關注正在影響組織診斷市場。對癌症生物學認知的不斷深入，增加了對能夠識別與不同癌症類型相關的特定生物標記的診斷測試的需求。這一趨勢正在推動伴隨診斷的發展，以指導治療決策並改善治療效果。此外，對腫瘤學研發的日益重視也推動了組織診斷領域的創新，促使新型檢測方法和技術的出現，從而提升了診斷能力。

此外，旨在提高癌症篩檢和診斷水準的宣傳活動和措施的不斷增加，也促進了組織診斷市場的成長。隨著患者對早期檢測重要性的認知不斷提高，對可靠且便捷的診斷解決方案的需求預計將會上升。學術機構、研究組織和產業相關人員之間的合作也在推動組織診斷技術的進步，確保新技術能夠滿足醫療服務提供者和患者不斷變化的需求。

目錄

第1章 引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 繪製滲透率和成長前景圖
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 市場問題
• 波特五力分析
• PESTLE分析

4. 全球組織診斷市場（依產品分類）

• 市場分析、洞察與預測
• 耗材（抗體、試劑盒、試劑、探針）
• 設備 A（載玻片染色系統、掃描器、組織處理系統、其他設備（自動蓋玻片機、切片機、包埋系統、石蠟分配器和載玻片標籤機））

5. 全球組織診斷市場（依技術分類）

• 市場分析、洞察與預測
• 免疫組織化學
• 原位雜合反應
• 數位病理學和工作流程管理
• 特殊染色

6. 全球組織診斷市場（依疾病類型分類）

• 市場分析、洞察與預測
• 乳癌
• 胃癌
• 淋巴瘤
• 攝護腺癌
• 非小細胞肺癌
• 其他疾病類型（神經系統疾病、心血管疾病、免疫系統疾病、感染疾病、骨癌、結腸癌、甲狀腺癌、子宮頸癌、皮膚癌、膽囊癌、B型肝炎病毒、EBEB病毒、肝炎、肌肉萎縮症、腎細胞癌、多形性肉瘤）

7. 全球組織診斷市場（以最終用戶分類）

• 市場分析、洞察與預測
• 醫院
• 研究實驗室
• 製藥公司
• 受託研究機構（CRO）
• 其他最終用戶（參考實驗室和學術實驗室）

8. 全球組織診斷市場（依地區分類）

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商格局（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • F. Hoffmann-La Roche Ltd
  • Danaher Corporation
  • PHC Holdings Corporation
  • Agilent Technologies Inc
  • Thermo Fisher Scientific Inc
  • Abbott Laboratories
  • GE Healthcare
  • Cell Signaling TechnologyInc
  • BioGenex
  • Siemens

The Tissue Diagnostics Market size is expected to reach USD 15.78 Billion in 2034 from USD 7.24 Billion (2025) growing at a CAGR of 9.04% during 2026-2034.

The tissue diagnostics market is poised for significant growth, driven by the increasing prevalence of cancer and the rising demand for accurate and timely diagnostic solutions. As healthcare providers seek to improve patient outcomes through early detection and personalized treatment plans, the need for advanced tissue diagnostic technologies is surging. Innovations in histopathology, immunohistochemistry, and molecular diagnostics are enhancing the accuracy and efficiency of tissue analysis, enabling healthcare professionals to make informed decisions regarding patient care. The integration of digital pathology and artificial intelligence is further transforming the landscape, allowing for more precise image analysis and improved workflow in laboratories.

Moreover, the growing emphasis on personalized medicine is influencing the tissue diagnostics market. As the understanding of cancer biology advances, there is a rising demand for diagnostic tests that can identify specific biomarkers associated with different cancer types. This trend is driving the development of companion diagnostics that guide treatment decisions and improve therapeutic outcomes. Additionally, the increasing focus on research and development in oncology is fostering innovation in tissue diagnostics, leading to the introduction of novel assays and technologies that enhance diagnostic capabilities.

Furthermore, the rise of awareness campaigns and initiatives aimed at improving cancer screening and diagnosis is contributing to the growth of the tissue diagnostics market. As patients become more informed about the importance of early detection, the demand for reliable and accessible diagnostic solutions is expected to rise. Collaborations between academic institutions, research organizations, and industry players are also driving advancements in tissue diagnostics, ensuring that new technologies meet the evolving needs of healthcare providers and patients.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Consumables (Antibodies, Kits, Reagents, Probes)
• InstrumentsA (Slide-staining Systems, Scanners, Tissue-processing Systems, Other Instruments (Automated Cover Slippers, Microtomes, Embedding Systems, Paraffin Dispensers, And Slide Labelers))

By Technology

• Immunohistochemistry
• In Situ Hybridization
• Digital Pathology & Workflow Management
• Special Staining

By Disease Type

• Breast Cancer
• Gastric Cancer
• Lymphoma
• Prostate Cancer
• Non-small Cell Lung Cancer
• Other Disease Types (Neurological Disease, Cardiovascular Disease, Immunological Diseases, Infectious Diseases, Cancers Of The Bone, Colon, Thyroid, Cervix, And Skin, Gallbladder Carcinoma, Hbv, Epstein-Barr Virus, Hepatitis, Muscular Dystrophy, Renal Cell Carcinoma, And Pleomorphic Sarcomas.)

By End User

• Hospitals
• Research Laboratories
• Pharmaceutical Companies
• Contract Research Organizations (CROs)
• Other End Users (Reference Laboratories And Academic Research Laboratories)

COMPANIES PROFILED

• F HoffmannLa Roche Ltd, Danaher Corporation, PHC Holdings Corporation, Agilent Technologies Inc, Thermo Fisher Scientific Inc, Abbott Laboratories, GE Healthcare, Cell Signaling Technology, Inc, BioGenex, Siemens

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL TISSUE DIAGNOSTICS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Consumables (Antibodies, Kits, Reagents, Probes) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. InstrumentsA (Slide-staining Systems, Scanners, Tissue-processing Systems, Other Instruments (Automated Cover Slippers, Microtomes, Embedding Systems, Paraffin Dispensers, And Slide Labelers)) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL TISSUE DIAGNOSTICS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Immunohistochemistry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. In Situ Hybridization Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Digital Pathology & Workflow Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Special Staining Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL TISSUE DIAGNOSTICS MARKET: BY DISEASE TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Disease Type
• 6.2. Breast Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Gastric Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Lymphoma Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Prostate Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Non-small Cell Lung Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Other Disease Types (Neurological Disease, Cardiovascular Disease, Immunological Diseases, Infectious Diseases, Cancers Of The Bone, Colon, Thyroid, Cervix, And Skin, Gallbladder Carcinoma, Hbv, Epstein-Barr Virus, Hepatitis, Muscular Dystrophy, Renal Cell Carcinoma, And Pleomorphic Sarcomas.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL TISSUE DIAGNOSTICS MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Research Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Contract Research Organizations (CROs) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Other End Users (Reference Laboratories And Academic Research Laboratories) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL TISSUE DIAGNOSTICS MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Technology
  • 8.2.3 By Disease Type
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Technology
  • 8.3.3 By Disease Type
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Technology
  • 8.4.3 By Disease Type
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Technology
  • 8.5.3 By Disease Type
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Technology
  • 8.6.3 By Disease Type
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL TISSUE DIAGNOSTICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 F. Hoffmann-La Roche Ltd
  • 10.2.2 Danaher Corporation
  • 10.2.3 PHC Holdings Corporation
  • 10.2.4 Agilent Technologies Inc
  • 10.2.5 Thermo Fisher Scientific Inc
  • 10.2.6 Abbott Laboratories
  • 10.2.7 GE Healthcare
  • 10.2.8 Cell Signaling TechnologyInc
  • 10.2.9 BioGenex
  • 10.2.10 Siemens